This is the first report on the long-term durability of response among complete responders to mitomycin C chemoablation of low-grade upper tract urothelial carcinoma.

On January 28, 2025, and February 25, 2025, Urology Times conducted case-based roundtable discussions on the topic of upper tract urothelial cancer (UTUC). The programs were moderated by Katie S.

Join Nirmish Singla, MD, MSC, Associate Professor of Urology and Oncology to learn more about updates, progress, and recognition of UTUC as its own unique disease.

Background and objective: To explore the risk factors and construct a prediction model of the lymphovascular invasion (LVI) in patients with upper tract urothelial carcinoma (UTUC). Methods: Clinical ...

Arnulf Stenzl and Alison Birtle debated whether neoadjuvant or adjuvant systemic therapy is best for high-risk upper tract urothelial carcinoma (UTUC) patients. Dr. Stenzl supported neoadjuvant ...

肾盂输尿管癌（Upper Tract Urothelial Carcinoma, UTUC）是一种罕见的泌尿系统恶性肿瘤，起源于肾盂或输尿管的上皮细胞，多数患者以肾积水或无痛肉眼血尿就诊， 早期肿瘤影像学检查很难发现，容易与结石、炎症等疾病混淆。